Localized bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor treatment

Eur J Dermatol. 2018 Apr 1;28(2):250-251. doi: 10.1684/ejd.2018.3230.
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Biopsy, Needle
  • Complement C3-C5 Convertases / immunology
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptidyl-Peptidase IV Inhibitors / adverse effects*
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use
  • Enzyme-Linked Immunosorbent Assay
  • Fluorescent Antibody Technique, Direct
  • Follow-Up Studies
  • Humans
  • Immunoglobulin G / immunology
  • Immunohistochemistry
  • Male
  • Pemphigoid, Bullous / chemically induced*
  • Pemphigoid, Bullous / pathology*
  • Risk Assessment
  • Severity of Illness Index
  • Sitagliptin Phosphate / adverse effects*
  • Sitagliptin Phosphate / therapeutic use
  • Withholding Treatment

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Immunoglobulin G
  • Complement C3-C5 Convertases
  • Sitagliptin Phosphate